Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05508256 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction

Study acronym: CABA-HFPEF
StatusRecruiting
PhasePhase 4
Started2023-03
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 6, 2023 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2023-03-03
notable
Not Yet Recruiting→Recruiting Study Identification, Study Status, Study Design, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start date2022-08→2023-03
Eligibility criteria+98 characters
InclusionINCLUSION CriteriaCRITERIA: Age ≥18 years Signed written informed consent Clinical evi [...] II) Paroxysmal or persistent atrial fibrillation (less than 1224 months andafter notfirst longer than 24 monthsdiagnosis, documented at least on one 12-lead ECG) Left ventricular e [...] gs (any local measurement made during the screening epoch): A. LA enlargement defined by at least 1 of the following: LA wi [...] ea ≥20 cm2 or LA volume ≥55 ml or LA volume index ≥29 ml/m2 B. Left ventricular hypertrophy (septal thickness or posterior wall thickness ≥1.1cm1 cm or relative wall thickness >0.42) Patients with at le [...] [...]
Secondary endpoints12 to 13 entries
Stroke Total (first and recurrent) unplanned cardiovascular hospitalization (HF,for heart failure or acute coronary syndrome, or stroke) Number of nightsNights spent in hospital Number of daysDays alive and out of hospital AFAtrial fibrillation burden (percentage of AF at 12 months FU Holter ECG) Percentage changeChange in left ventricular ejection fraction at 12 months FU Change in NYHA class (I-IV) at 12 months FU Change in EHRA score (I-IV) at 12 months FU Change in quality of life at 12 months FU (measured by KCCQ score)
Primary endpoints1 entry, revised
The primary outcome is defined as survival time free of thea composite of cardiovascular death, stroke and total (first and recurrent) unplanned cardiovascular hospitalization (Heartfor heart failure, or acute coronary syndrome or stroke).
Study sitesdetails revised at 1 of 1 site
Study title+8 characters
CAtheter-Based Ablation of Atrial Fibrillation vs.Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction
2022-08-17
minor
Original filing
The objective of CABA-HFPEF is to test whether catheter ablation (CA) for atrial fibrillation (AF) can prevent adverse cardiovascular outcomes in patients with heart failure with preserved (HFpEF) or mildly reduced ejection fraction (HFmrEF).
Trial Details
NCT Number NCT05508256
Lead Sponsor Charite University, Berlin, Germany
Collaborators: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Kompetenznetz Vorhofflimmern e.V. (AFNET), Boston Scientific Corporation
Conditions Atrial Fibrillation, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Enrollment 1,548 participants
Start Date 2023-03
Primary Completion 2026-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2023-03-06